3
Announcements
Trials
Browse
Landscape
Phase
Phase 1/2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Infectious Mononucleosis
1
Epstein-Barr Virus Infections
1
Interventions
Rituximab
4
Valganciclovir
2
Valacyclovir
2
Carboplatin
2
Acyclovir
2
valomaciclovir
1
threonic acid
1
otelixizumab
1
cc-486
1
Zidovudine
1
Vincristine
1
Vaccines
1
Tomography, X-Ray Computed
1
Prednisone
1
Polymerase Chain Reaction
1
Methotrexate
1
Matrix-M
1
Magnesium Sulfate
1
MVA vaccine
1
Leucovorin
1
Kidney Transplantation
1
Interferons
1
In Situ Hybridization
1
Immunohistochemistry
1
Granulocyte Colony-Stimulating Factor
1
Gene-Eden-VIR
1
Gastrectomy
1
Flow Cytometry
1
Filgrastim
1
Etoposide
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Epstein-Barr Virus Infections
×
valomaciclovir
×
Clear all
NCT00575185
2017-03-22
Mono6
University of Minnesota
Phase 1/2
Completed
23 enrolled
8 charts